Regulation of nitric oxide biosynthesis : cofactor requirement and enzymatic characteristics. DiscussionKILBOURN, R. G.Research in immunology (Paris). 1991, Vol 142, Num 7, pp 587-600, issn 0923-2494Article

Synthesis of N-tert-butyl-α-(4-[¹⁸F]fluorophenyl)-nitrone ([¹⁸F]FPBN) for in vivo detection of free radicalsBORMANS, G; KILBOURN, R.Journal of labelled compounds & radiopharmaceuticals. 1995, Vol 36, Num 2, pp 103-110, issn 0362-4803Article

The role of nitric oxide in interleukin-2 therapy induced hypotensionSHAHIDI, H; KILBOURN, R. G.Cancer metastasis reviews. 1998, Vol 17, Num 1, pp 119-126, issn 0167-7659Article

Endothelial cell production of nitrogen oxides in response to interferon γ in combination with tumor necrosis factor, interleukin-1, or endotoxinKILBOURN, R. G; BELLONI, P.Journal of the National Cancer Institute. 1990, Vol 82, Num 9, pp 772-776, issn 0027-8874Article

Mononuclear phagocyte system cytotoxins: a reviewLOPEZ-BERESTEIN, G; KILBOURN, R.Natural immunity and cell growth regulation. 1985, Vol 4, Num 2, pp 78-89, issn 0254-7600Article

Paclitaxel, cisplatin and methotrexate combination chemotherapy is active in the treatment of refractory urothelial malignanciesSHI-MING TU; HOSSAN, E; AMATO, R et al.The Journal of urology. 1995, Vol 154, Num 5, pp 1719-1722, issn 0022-5347Article

5-Fluorouracil and interferon-α in chemotherapy refractory bladder carcinoma : an effective regimenLOGOTHETIS, C. J; HOSSAN, E; RECONDO, G et al.Anticancer research. 1994, Vol 14, Num 3B, pp 1265-1269, issn 0250-7005Article

A phase I trial of intermittent high-dose α-interferon and dexamethasone in metastatic renal cell carcinomaAMATO, R; MEYERS, C; ELLERHORST, J et al.Annals of oncology. 1995, Vol 6, Num 9, pp 911-914, issn 0923-7534Article

Phase II study of interferon-α and chemotherapy (5-fluorouracil and mitomycin C) in metastatic renal cell cancer. Editorial commments. Author's replySELLA, A; LOGOTHETIS, C. J; FITZ, K et al.The Journal of urology. 1992, Vol 147, Num 3, pp 573-577, issn 0022-5347, 1Article

Association of germ cell tumors and Hodgkin's diseaseDEXEUS, F. H; LOGOTHETIS, C. J; KILBOURN, R et al.Urology (Ridgewood, NJ). 1991, Vol 37, Num 2, pp 129-134, issn 0090-4295, 6 p.Article

Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tractDEXEUS, F. H; LOGOTHETIS, C. J; SELLA, A et al.The Journal of urology. 1991, Vol 146, Num 5, pp 1284-1287, issn 0022-5347Article

Radiolabeled hypoxic cell sensitizers: tracers for assessment of ischemiaMATHIAS, C. J; WELCH, M. J; KILBOURN, R et al.Life sciences (1973). 1987, Vol 41, Num 2, pp 199-206, issn 0024-3205Article

COMPARATIVE FUNCTIONAL ANALYSIS OF LYMPHOCYTES AND MONOCYTES FROM PLATELETAPHERESISLOPEZ BERESTEIN G; REUBEN J; HERSH EM et al.1983; TRANSFUSION (PHILADELPHIA); ISSN 0041-1132; USA; DA. 1983; VOL. 23; NO 3; PP. 201-206; BIBL. 15 REF.Article

Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aortaJOLY, G. A; NARAYANAN, K; GRIFFITH, O. W et al.British journal of pharmacology. 1995, Vol 115, Num 3, pp 491-497, issn 0007-1188Article

Cell-free hemoglobin reverses the endotoxin-mediated hyporesponsivity of rat aortic rings to α-adrenergic agentsKILBOURN, R. G; JOLY, G; CASHON, B et al.Biochemical and biophysical research communications (Print). 1994, Vol 199, Num 1, pp 155-162, issn 0006-291XArticle

N^G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension : implications for the involvement of nitric oxideKILBOURN, R. G; GROSS, S. S; JUBRAN, A et al.Proceedings of the National Academy of Sciences of the United States of America. 1990, Vol 87, Num 9, pp 3629-3632, issn 0027-8424, 4 p.Article

Escalated therapy for refractory urothelial tumors : methotrexate-vinblastine-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-stimulating factorLOGOTHETIS, C. J; DEXEUS, F. H; SELLA, A et al.Journal of the National Cancer Institute. 1990, Vol 82, Num 8, pp 667-672, issn 0027-8874Article

N^G-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotensionKILBOURN, R. G; FONSECA, G. A; GRIFFITH, O. W et al.Critical care medicine. 1995, Vol 23, Num 6, pp 1018-1024, issn 0090-3493Article

Phase I study of interleukin-2 combined with interferon-α and 5-fluorouracil in patients with metastatic renal cell cancerAVISHAY SELLA; KILBOURN, R. G; GRAY, I et al.Cancer biotherapy. 1994, Vol 9, Num 2, pp 103-111, issn 1062-8401Article

N^G-methyl-L-arginine, an inhibitor of nitric oxide formation, reverses IL-2-mediated hypotension in dogsKILBOURN, R. G; OWEN-SCHAUB, L. B; CROMEENS, D. M et al.Journal of applied physiology (1985). 1994, Vol 76, Num 3, pp 1130-1137, issn 8750-7587Article

Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial tumors : results of a randomized trialLOGOTHETIS, C. J; FINN, L. D; SMITH, T et al.Journal of clinical oncology. 1995, Vol 13, Num 9, pp 2272-2277, issn 0732-183XArticle

Drug-induced vasodilation in an in vitro and in vivo study : The effects of nicardipine, papaverine, and lidocaine on the rabbit carotid arteryEVANS, G. R. D; GHERARDINI, G; LUNDEBERG, T et al.Plastic and reconstructive surgery (1963). 1997, Vol 100, Num 6, pp 1475-1481, issn 0032-1052Article